BRIEF-Acura pharma up 12.4 percent premarket; says FDA to review data from failed painkiller trial

NEW YORK Mon Dec 9, 2013 8:03am EST

NEW YORK Dec 9 (Reuters) - Acura Pharmaceuticals Inc : * Pharma up 12.4 percent to $1.90 premarket; says FDA to review data from failed painkiller trial

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.